It has been demonstrated recently that high expression of CX3CL1 in colorectal cancer was significantly associated with more favorable patients’ prognosis whereas low expression identifies a subset of patients with significantly higher risk of developing distant metastasis and rapid tumor progression (32). This evidence concerns the gene CX3CL1 and neoplasm.